TRISTAN BLANCHETTE: Open Payments
NPI 1780265793 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 31 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $259 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $195 |
| Orexo US, Inc. | 6 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Indivior Inc. | 2 | $59 |
| Braeburn Inc. | 2 | $38 |
| Exact Sciences Corporation | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: MAVYRET, Zubsolv, CAPLYTA, REXULTI, VRAYLAR, SUBLOCADE, BRIXADI, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
